EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantitative performance of humanized serum and epithelial lining fluid exposures of tigecycline and levofloxacin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model

Andrew J Fratoni, Alissa M Padgett, Erin M Duffy, David P Nicolau iD

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Andrew J Fratoni und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA. Hauptthemen laut MEDLINE: Tigecycline, Klebsiella pneumoniae, Pseudomonas aeruginosa, Levofloxacin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, Germany's Federal Ministry of Education and Research, The U.S. National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lack of uniformity in infection models complicates preclinical development. The COMBINE protocol has standardized the murine neutropenic pneumonia model. Herein we provide benchmark efficacy data of humanized exposures of tigecycline and levofloxacin in plasma and epithelial lining fluid (ELF) against a collection of Klebsiella pneumoniae and Pseudomonas aeruginosa.

Methods

Following the COMBINE protocol, plasma and ELF human-simulated regimens (HSRs) of tigecycline 100 mg followed by 50 mg q12h and levofloxacin 750 mg once daily were developed and confirmed in the murine neutropenic pneumonia model. Tigecycline HSRs were tested against seven K. pneumoniae isolates. Levofloxacin HSRs were assessed against 10 K. pneumoniae and 9 P. aeruginosa. The change in cfu/lung over 24 h for each treatment was calculated. Each isolate was tested in duplicate against both the plasma and ELF HSRs on separate experiment days.

Results

Tigecycline 1.8 and 3 mg/kg q12h achieved humanized exposures of serum and ELF, respectively. Levofloxacin 120 and 90 mg/kg q8h led to fAUC exposures in plasma and ELF similar to in humans. Both tigecycline regimens were ineffective across the MIC range. Levofloxacin regimens achieved multilog kill against susceptible isolates, and no appreciable cfu/lung reductions in isolates with an MIC of ≥32 mg/L. Differences in cfu/lung were evident between the levofloxacin plasma and ELF HSRs against isolates with MICs of 4 and 8 mg/L.

Conclusions

Administering HSRs of tigecycline and levofloxacin based on both serum/plasma and ELF in the COMBINE pneumonia model resulted in cfu/lung values reasonably aligned with MIC. These data serve as translational benchmarks for future investigations with novel compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TigecyclineKlebsiella pneumoniaePseudomonas aeruginosaLevofloxacinAnti-Bacterial AgentsDisease Models, AnimalMicrobial Sensitivity TestsPneumonia, BacterialPseudomonas InfectionsKlebsiella InfectionsAnimalsMiceHumansMinocyclineNeutropeniaFemaleSerum

Substanzen

TigecyclineLevofloxacinAnti-Bacterial AgentsMinocycline

Autor:innen und Institutionen

  • Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.
  • CARB-X, Boston, MA, USA.

ORCID-Profile: David P Nicolau

Förderung

  • NIEHS NIH HHS
  • Germany's Federal Ministry of Education and Research
  • The U.S. National Institute of Allergy and Infectious Diseases
  • CARB-X
  • Wellcome
  • Gates Foundation
  • NIH HHS
  • Wellcome Trust

Zitieren

APA

Fratoni, A. J., Padgett, A. M., Duffy, E. M., & Nicolau, D. P. (2024). Quantitative performance of humanized serum and epithelial lining fluid exposures of tigecycline and levofloxacin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae333

Vancouver

Fratoni AJ, Padgett AM, Duffy EM, Nicolau DP. Quantitative performance of humanized serum and epithelial lining fluid exposures of tigecycline and levofloxacin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae333

BibTeX
@article{Fratoni2024,
  author = {Fratoni, Andrew J and Padgett, Alissa M and Duffy, Erin M and Nicolau, David P},
  title = {Quantitative performance of humanized serum and epithelial lining fluid exposures of tigecycline and levofloxacin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae333}
}
Kostenlos starten →